Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Polyps 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Infections 1 Adenomatous Polyposis Coli 1

Interventions

Cyclophosphamide 17 Rituximab 12 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Filgrastim 7 sargramostim 6 Vincristine 6 fludarabine phosphate 5 Radiotherapy 5 Doxorubicin 5 Cytarabine 5 Cisplatin 5 ibritumomab tiuxetan 4 Methylprednisolone 4 Melphalan 4 Etoposide 4 Dexamethasone 4 Cyclosporine 4 epratuzumab 3 Sensitivity and Specificity 3 Polymerase Chain Reaction 3 Mycophenolic Acid 3 Indium 3 Chlorambucil 3 Busulfan 3 Bendamustine Hydrochloride 3 Antilymphocyte Serum 3 Antigens, CD19 3 obinutuzumab 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma, Follicular × Docosahexaenoic Acids × Clear all

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡